{"id":37618,"date":"2023-03-21T14:31:48","date_gmt":"2023-03-21T13:31:48","guid":{"rendered":"https:\/\/genomtec.com\/?p=37618"},"modified":"2023-03-21T14:33:15","modified_gmt":"2023-03-21T13:33:15","slug":"genomtec-wants-the-shareholders-to-participate-in-the-benefits-of-the-potential-ma-transaction-to-the-largest-possible-extent","status":"publish","type":"post","link":"https:\/\/genomtec.com\/en\/2023\/03\/21\/genomtec-wants-the-shareholders-to-participate-in-the-benefits-of-the-potential-ma-transaction-to-the-largest-possible-extent\/","title":{"rendered":"Genomtec wants the Shareholders to participate in the benefits of the potential M&A transaction to the largest possible extent"},"content":{"rendered":"

According to the adopted resolution, the Issuer’s Management Board will take all reasonable steps to ensure the Shareholders’ participation in the benefits of the potential sale of the technology to the widest possible extent. This includes the call by the potential buyer for all of the Issuer’s shares or allocating the entire profit obtained by the Company as a result of the potential sale of technology.<\/p>\n

More information: https:\/\/www.parkiet.com\/medycyna-i-zdrowie\/art38165201-genomtec-chce-dopiescic-akcjonariuszy<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

According to the adopted resolution, the Issuer’s Management Board will take all reasonable steps to ensure the Shareholders’ participation in the benefits of the potential sale of the technology to the widest possible extent. This includes the call by the potential buyer for all of the Issuer’s shares or allocating the entire profit obtained by […]<\/p>\n","protected":false},"author":1,"featured_media":36430,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[5],"tags":[],"class_list":["post-37618","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"yoast_head":"\nGenomtec wants the Shareholders to participate in the benefits of the potential M&A transaction to the largest possible extent - Genomtec<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/genomtec.com\/en\/2023\/03\/21\/genomtec-wants-the-shareholders-to-participate-in-the-benefits-of-the-potential-ma-transaction-to-the-largest-possible-extent\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Genomtec wants the Shareholders to participate in the benefits of the potential M&A transaction to the largest possible extent - Genomtec\" \/>\n<meta property=\"og:description\" content=\"According to the adopted resolution, the Issuer’s Management Board will take all reasonable steps to ensure the Shareholders’ participation in the benefits of the potential sale of the technology to the widest possible extent. This includes the call by the potential buyer for all of the Issuer’s shares or allocating the entire profit obtained by […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/genomtec.com\/en\/2023\/03\/21\/genomtec-wants-the-shareholders-to-participate-in-the-benefits-of-the-potential-ma-transaction-to-the-largest-possible-extent\/\" \/>\n<meta property=\"og:site_name\" content=\"Genomtec\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-21T13:31:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-21T13:33:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/genomtec.com\/wp-content\/uploads\/2022\/05\/news_raport_q1_2022.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1900\" \/>\n\t<meta property=\"og:image:height\" content=\"879\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin@genomtec.com\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/genomtec.com\/#website\",\"url\":\"https:\/\/genomtec.com\/\",\"name\":\"Genomtec\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/genomtec.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/genomtec.com\/en\/2023\/03\/21\/genomtec-wants-the-shareholders-to-participate-in-the-benefits-of-the-potential-ma-transaction-to-the-largest-possible-extent\/#primaryimage\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/genomtec.com\/wp-content\/uploads\/2022\/05\/news_raport_q1_2022.jpg\",\"contentUrl\":\"https:\/\/genomtec.com\/wp-content\/uploads\/2022\/05\/news_raport_q1_2022.jpg\",\"width\":1900,\"height\":879},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/genomtec.com\/en\/2023\/03\/21\/genomtec-wants-the-shareholders-to-participate-in-the-benefits-of-the-potential-ma-transaction-to-the-largest-possible-extent\/#webpage\",\"url\":\"https:\/\/genomtec.com\/en\/2023\/03\/21\/genomtec-wants-the-shareholders-to-participate-in-the-benefits-of-the-potential-ma-transaction-to-the-largest-possible-extent\/\",\"name\":\"Genomtec wants the Shareholders to participate in the benefits of the potential M&A transaction to the largest possible extent - Genomtec\",\"isPartOf\":{\"@id\":\"https:\/\/genomtec.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/genomtec.com\/en\/2023\/03\/21\/genomtec-wants-the-shareholders-to-participate-in-the-benefits-of-the-potential-ma-transaction-to-the-largest-possible-extent\/#primaryimage\"},\"datePublished\":\"2023-03-21T13:31:48+00:00\",\"dateModified\":\"2023-03-21T13:33:15+00:00\",\"author\":{\"@id\":\"https:\/\/genomtec.com\/#\/schema\/person\/1a341d12370a22429e0515e03f637ecf\"},\"breadcrumb\":{\"@id\":\"https:\/\/genomtec.com\/en\/2023\/03\/21\/genomtec-wants-the-shareholders-to-participate-in-the-benefits-of-the-potential-ma-transaction-to-the-largest-possible-extent\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/genomtec.com\/en\/2023\/03\/21\/genomtec-wants-the-shareholders-to-participate-in-the-benefits-of-the-potential-ma-transaction-to-the-largest-possible-extent\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/genomtec.com\/en\/2023\/03\/21\/genomtec-wants-the-shareholders-to-participate-in-the-benefits-of-the-potential-ma-transaction-to-the-largest-possible-extent\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Genomtec wants the Shareholders to participate in the benefits of the potential M&A transaction to the largest possible extent\"}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/genomtec.com\/#\/schema\/person\/1a341d12370a22429e0515e03f637ecf\",\"name\":\"admin@genomtec.com\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/genomtec.com\/#personlogo\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9e9cc6dab1109231f0b60cf5e90342d08d0039171ecbc1d500786ee9c62be7e7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9e9cc6dab1109231f0b60cf5e90342d08d0039171ecbc1d500786ee9c62be7e7?s=96&d=mm&r=g\",\"caption\":\"admin@genomtec.com\"},\"url\":\"https:\/\/genomtec.com\/en\/author\/admingenomtec-com\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Genomtec wants the Shareholders to participate in the benefits of the potential M&A transaction to the largest possible extent - Genomtec","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/genomtec.com\/en\/2023\/03\/21\/genomtec-wants-the-shareholders-to-participate-in-the-benefits-of-the-potential-ma-transaction-to-the-largest-possible-extent\/","og_locale":"en_US","og_type":"article","og_title":"Genomtec wants the Shareholders to participate in the benefits of the potential M&A transaction to the largest possible extent - Genomtec","og_description":"According to the adopted resolution, the Issuer’s Management Board will take all reasonable steps to ensure the Shareholders’ participation in the benefits of the potential sale of the technology to the widest possible extent. This includes the call by the potential buyer for all of the Issuer’s shares or allocating the entire profit obtained by […]","og_url":"https:\/\/genomtec.com\/en\/2023\/03\/21\/genomtec-wants-the-shareholders-to-participate-in-the-benefits-of-the-potential-ma-transaction-to-the-largest-possible-extent\/","og_site_name":"Genomtec","article_published_time":"2023-03-21T13:31:48+00:00","article_modified_time":"2023-03-21T13:33:15+00:00","og_image":[{"width":1900,"height":879,"url":"https:\/\/genomtec.com\/wp-content\/uploads\/2022\/05\/news_raport_q1_2022.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin@genomtec.com","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebSite","@id":"https:\/\/genomtec.com\/#website","url":"https:\/\/genomtec.com\/","name":"Genomtec","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/genomtec.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"ImageObject","@id":"https:\/\/genomtec.com\/en\/2023\/03\/21\/genomtec-wants-the-shareholders-to-participate-in-the-benefits-of-the-potential-ma-transaction-to-the-largest-possible-extent\/#primaryimage","inLanguage":"en-US","url":"https:\/\/genomtec.com\/wp-content\/uploads\/2022\/05\/news_raport_q1_2022.jpg","contentUrl":"https:\/\/genomtec.com\/wp-content\/uploads\/2022\/05\/news_raport_q1_2022.jpg","width":1900,"height":879},{"@type":"WebPage","@id":"https:\/\/genomtec.com\/en\/2023\/03\/21\/genomtec-wants-the-shareholders-to-participate-in-the-benefits-of-the-potential-ma-transaction-to-the-largest-possible-extent\/#webpage","url":"https:\/\/genomtec.com\/en\/2023\/03\/21\/genomtec-wants-the-shareholders-to-participate-in-the-benefits-of-the-potential-ma-transaction-to-the-largest-possible-extent\/","name":"Genomtec wants the Shareholders to participate in the benefits of the potential M&A transaction to the largest possible extent - Genomtec","isPartOf":{"@id":"https:\/\/genomtec.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/genomtec.com\/en\/2023\/03\/21\/genomtec-wants-the-shareholders-to-participate-in-the-benefits-of-the-potential-ma-transaction-to-the-largest-possible-extent\/#primaryimage"},"datePublished":"2023-03-21T13:31:48+00:00","dateModified":"2023-03-21T13:33:15+00:00","author":{"@id":"https:\/\/genomtec.com\/#\/schema\/person\/1a341d12370a22429e0515e03f637ecf"},"breadcrumb":{"@id":"https:\/\/genomtec.com\/en\/2023\/03\/21\/genomtec-wants-the-shareholders-to-participate-in-the-benefits-of-the-potential-ma-transaction-to-the-largest-possible-extent\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/genomtec.com\/en\/2023\/03\/21\/genomtec-wants-the-shareholders-to-participate-in-the-benefits-of-the-potential-ma-transaction-to-the-largest-possible-extent\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/genomtec.com\/en\/2023\/03\/21\/genomtec-wants-the-shareholders-to-participate-in-the-benefits-of-the-potential-ma-transaction-to-the-largest-possible-extent\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Genomtec wants the Shareholders to participate in the benefits of the potential M&A transaction to the largest possible extent"}]},{"@type":"Person","@id":"https:\/\/genomtec.com\/#\/schema\/person\/1a341d12370a22429e0515e03f637ecf","name":"admin@genomtec.com","image":{"@type":"ImageObject","@id":"https:\/\/genomtec.com\/#personlogo","inLanguage":"en-US","url":"https:\/\/secure.gravatar.com\/avatar\/9e9cc6dab1109231f0b60cf5e90342d08d0039171ecbc1d500786ee9c62be7e7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9e9cc6dab1109231f0b60cf5e90342d08d0039171ecbc1d500786ee9c62be7e7?s=96&d=mm&r=g","caption":"admin@genomtec.com"},"url":"https:\/\/genomtec.com\/en\/author\/admingenomtec-com\/"}]}},"_links":{"self":[{"href":"https:\/\/genomtec.com\/en\/wp-json\/wp\/v2\/posts\/37618","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genomtec.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/genomtec.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/genomtec.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/genomtec.com\/en\/wp-json\/wp\/v2\/comments?post=37618"}],"version-history":[{"count":0,"href":"https:\/\/genomtec.com\/en\/wp-json\/wp\/v2\/posts\/37618\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/genomtec.com\/en\/wp-json\/wp\/v2\/media\/36430"}],"wp:attachment":[{"href":"https:\/\/genomtec.com\/en\/wp-json\/wp\/v2\/media?parent=37618"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/genomtec.com\/en\/wp-json\/wp\/v2\/categories?post=37618"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/genomtec.com\/en\/wp-json\/wp\/v2\/tags?post=37618"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}